Karolinska Development AB ser. B
KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in th… Read more
Karolinska Development AB ser. B - Asset Resilience Ratio
Karolinska Development AB ser. B (KDEV) has an Asset Resilience Ratio of 0.88% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2025)
This chart shows how Karolinska Development AB ser. B's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Karolinska Development AB ser. B's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr9.27 Million | 0.88% |
| Total Liquid Assets | Skr9.27 Million | 0.88% |
Asset Resilience Insights
- Limited Liquidity: Karolinska Development AB ser. B maintains only 0.88% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Karolinska Development AB ser. B Industry Peers by Asset Resilience Ratio
Compare Karolinska Development AB ser. B's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Karolinska Development AB ser. B (2008–2025)
The table below shows the annual Asset Resilience Ratio data for Karolinska Development AB ser. B.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.88% | Skr9.27 Million | Skr1.05 Billion | -3.36pp |
| 2024-12-31 | 4.24% | Skr53.09 Million | Skr1.25 Billion | -3.36pp |
| 2023-12-31 | 7.60% | Skr95.66 Million | Skr1.26 Billion | -8.84pp |
| 2022-12-31 | 16.44% | Skr205.79 Million | Skr1.25 Billion | +8.11pp |
| 2021-12-31 | 8.33% | Skr92.40 Million | Skr1.11 Billion | -4.82pp |
| 2020-12-31 | 13.15% | Skr117.05 Million | Skr890.08 Million | +3.31pp |
| 2019-12-31 | 9.84% | Skr114.75 Million | Skr1.17 Billion | -7.64pp |
| 2018-12-31 | 17.48% | Skr138.85 Million | Skr794.38 Million | -8.10pp |
| 2017-12-31 | 25.58% | Skr169.63 Million | Skr663.26 Million | -31.04pp |
| 2016-12-31 | 56.61% | Skr248.15 Million | Skr438.32 Million | +11.43pp |
| 2015-12-31 | 45.19% | Skr277.65 Million | Skr614.46 Million | +37.68pp |
| 2014-12-31 | 7.51% | Skr128.44 Million | Skr1.71 Billion | -1.21pp |
| 2013-12-31 | 8.72% | Skr165.33 Million | Skr1.90 Billion | +0.86pp |
| 2012-12-31 | 7.86% | Skr174.16 Million | Skr2.21 Billion | -11.63pp |
| 2011-12-31 | 19.49% | Skr457.25 Million | Skr2.35 Billion | +11.79pp |
| 2010-12-31 | 7.70% | Skr136.61 Million | Skr1.77 Billion | +1.75pp |
| 2009-12-31 | 5.95% | Skr121.39 Million | Skr2.04 Billion | -12.13pp |
| 2008-12-31 | 18.09% | Skr301.00 Million | Skr1.66 Billion | -- |